These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 18983761)

  • 1. New guidelines for cytomegalovirus infection management in transplant recipients.
    Volpi A
    Herpes; 2008 Oct; 15(1):3. PubMed ID: 18983761
    [No Abstract]   [Full Text] [Related]  

  • 2. Quantitative measurement of cytomegalovirus load in pediatric solid transplant recipients: moving beyond antigenemia.
    Gonzàlez F; Allen U
    Pediatr Transplant; 2004 Aug; 8(4):309-12. PubMed ID: 15265152
    [No Abstract]   [Full Text] [Related]  

  • 3. Role of quantitative human cytomegalovirus PCR in predicting antiviral treatment response among high-risk hematopoietic stem-cell transplant recipients.
    Safdar A; Bruorton M; Henslee-Downey JP; van Rhee F
    Bone Marrow Transplant; 2004 Feb; 33(4):463-4. PubMed ID: 14716349
    [No Abstract]   [Full Text] [Related]  

  • 4. Monitoring transplant patients for human cytomegalovirus: Diagnostic update.
    Gerna G; Lilleri D
    Herpes; 2006 May; 13(1):4-11. PubMed ID: 16732996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of antigenemia assay and semiquantitative polymerase chain reaction test for monitoring active cytomegalovirus infection in allogeneic hematopoietic cell transplant recipients.
    Pajand O; Ziyaeyan M; Mousavi S; Fatolahzadeh B; Hojabri Z; Bahador A; Abdossamadi Z
    Exp Clin Transplant; 2008 Jun; 6(2):149-54. PubMed ID: 18816243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimization of outcomes related to cytomegalovirus in organ transplant recipients.
    Singh N
    Transplantation; 2006 Jul; 82(1):15-6. PubMed ID: 16861935
    [No Abstract]   [Full Text] [Related]  

  • 7. Quantification of human cytomegalovirus DNA by a new capture hybrid polymerase chain reaction enzyme-linked immunosorbent assay in plasma and peripheral blood mononuclear cells of bone marrow transplant recipients.
    Ziyaeyan M; Sabahi F; Alborzi A; Ramzi M; Mahboudi F; Pourabbas B; Kadivar M
    Exp Clin Transplant; 2008 Dec; 6(4):294-300. PubMed ID: 19338492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contemporary management of cytomegalovirus infection in transplant recipients: guidelines from an IHMF workshop, 2007.
    Griffiths P; Whitley R; Snydman DR; Singh N; Boeckh M;
    Herpes; 2008 Oct; 15(1):4-12. PubMed ID: 18983762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical utility of cytomegalovirus viral load in solid organ transplant recipients.
    Dioverti MV; Razonable RR
    Curr Opin Infect Dis; 2015 Aug; 28(4):317-22. PubMed ID: 26098497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diagnosis and treatment of cytomegaloviral chorioretinitis].
    Aznabaev MT; Mal'khanov VB; Mambetkulova GK; Ishberdina lSh
    Vestn Oftalmol; 2004; 120(6):41-3. PubMed ID: 15678675
    [No Abstract]   [Full Text] [Related]  

  • 11. Cytomegalovirus infection and disease in the new era of immunosuppression following solid organ transplantation.
    Fisher RA
    Transpl Infect Dis; 2009 Jun; 11(3):195-202. PubMed ID: 19228345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ganciclovir-resistant cytomegalovirus disease in heart transplant recipients: the dilemma of donor-positive/recipient-negative serostatus.
    Avery RK
    Clin Infect Dis; 2007 Aug; 45(4):448-9. PubMed ID: 17638192
    [No Abstract]   [Full Text] [Related]  

  • 13. Prophylaxis versus preemptive therapy for prevention of the consequences of cytomegalovirus infection in transplant recipients: a still unresolved issue.
    Potena L; Grigioni F; Magnani G; Branzi A
    Transplantation; 2009 Jan; 87(2):305-6; author reply 306-7. PubMed ID: 19155991
    [No Abstract]   [Full Text] [Related]  

  • 14. Antiviral strategies to combat cytomegalovirus infections in transplant recipients.
    Lischka P; Zimmermann H
    Curr Opin Pharmacol; 2008 Oct; 8(5):541-8. PubMed ID: 18662804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of antiviral prophylaxis in renal transplant recipients at high risk of cytomegalovirus infection.
    Costa C; Bergallo M; Cavallo R
    J Clin Virol; 2008 Jul; 42(3):293-4. PubMed ID: 18403256
    [No Abstract]   [Full Text] [Related]  

  • 16. Preemptive versus prophylactic approaches in the management of cytomegalovirus disease in solid organ transplant recipients: what we know and what we do not know.
    Meylan PR; Pascual M
    Clin Infect Dis; 2006 Oct; 43(7):881-3. PubMed ID: 16941369
    [No Abstract]   [Full Text] [Related]  

  • 17. Virus load dynamics of individual CMV-genotypes in lung transplant recipients with mixed-genotype infections.
    Görzer I; Kerschner H; Jaksch P; Bauer C; Seebacher G; Klepetko W; Puchhammer-Stöckl E
    J Med Virol; 2008 Aug; 80(8):1405-14. PubMed ID: 18551598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical features of cytomegalovirus anterior uveitis in immunocompetent patients.
    Knox DL
    Am J Ophthalmol; 2008 Oct; 146(4):625; author reply 625-6. PubMed ID: 18804562
    [No Abstract]   [Full Text] [Related]  

  • 19. Impact of genetic polymorphisms in cytomegalovirus glycoprotein B on outcomes in solid-organ transplant recipients with cytomegalovirus disease.
    Manuel O; Asberg A; Pang X; Rollag H; Emery VC; Preiksaitis JK; Kumar D; Pescovitz MD; Bignamini AA; Hartmann A; Jardine AG; Humar A
    Clin Infect Dis; 2009 Oct; 49(8):1160-6. PubMed ID: 19751151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytomegalovirus quantification: where to next in optimising patient management?
    Atkinson C; Emery VC
    J Clin Virol; 2011 Aug; 51(4):223-8. PubMed ID: 21620764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.